Amishi Y. Shah

Amishi Y. Shah is a Senior Professor at The University of Texas MD Anderson Cancer Center, specializing in genitourinary oncology, with a focus on kidney cancer, urothelial carcinoma, and radiation oncology. Her research centers on cancer immunotherapy, pharmacology, and the integration of circulating tumor DNA (ctDNA) and biomarkers like KIM-1 for prognostication in metastatic clear-cell renal cell carcinoma. Her recent work includes developing multivariable prognostic models for oligometastatic disease, characterizing brain metastases in small cell bladder cancer, and evaluating first-line ipilimumab and nivolumab outcomes across multi-institutional cohorts. She also investigates neoadjuvant immunotherapy combinations for cisplatin-ineligible urothelial carcinoma and metastasis-directed radiotherapy, contributing to advances in precision cancer care and treatment optimization.